Clinical Trial Update: Efficacy of Intradiscal Injection of BM-MSC in Subjects With Chronic Low Back Pain (LBP) Due to Lumbar Degenerative Disc Disease (DDD) Unresponsive [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on intradiscal injection of bone marrow-derived mesenchymal stem cells for chronic low back pain due to degenerative disc disease; Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Low Back Pain

Drugs mentioned

• Bone marrow-derived mesenchymal stem cells (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Recurrent Low Back Pain, Degenerative Disc Disease (DDD) | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING